NSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Insperity Inc (NSP) is not a strong buy for a beginner, long-term investor at this time. The stock is currently in a bearish trend with oversold technical indicators, weak financial performance in the most recent quarter, and mixed analyst sentiment. While there are some positive catalysts, such as hedge fund buying and potential long-term growth opportunities, the lack of immediate positive momentum and profitability challenges make this a hold rather than a buy.
The stock is in a bearish trend with the MACD histogram at -1.92, negatively expanding and below 0. The RSI of 6.931 indicates the stock is oversold. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 28.667 and 24.428, with resistance at 35.527 and 42.388.
Hedge funds are significantly increasing their buying activity (up 247.65% over the last quarter). Analysts from Roth Capital see potential for profit improvement in 2026 and beyond, with the company positioned for growth acceleration in 2027.
The company reported a negative adjusted EPS of -$0.60 for Q4 2025, missing expectations. Gross margin dropped by 25.25% YoY, and healthcare cost trends and stagnant small business hiring create uncertainty. Analysts have lowered price targets, and insider trading activity is neutral.
In Q4 2025, revenue grew by 3.41% YoY to $1.67 billion, but net income remained negative at -$33 million, albeit improving by 266.67% YoY. EPS improved to -$0.87, up 262.50% YoY, but gross margin dropped to 9.59%, down 25.25% YoY.
Analyst sentiment is mixed. Roth Capital maintains a Buy rating with a lowered price target of $56 (from $61), citing potential profit improvement in 2026. JPMorgan raised the price target slightly to $35 but maintains an Underweight rating. Baird lowered the price target to $36 with a Neutral rating, reflecting uncertainty in the near term.
